Superficial Mycoses in the Elderly

Shaikh S, Nellore A. Cutaneous Fungal Infections in Older Adults. Clin Geriatr Med. 2024;40(1):131-146. doi:10.1016/j.cger.2023.09.008.

Varade RS, Burkemper NM. Cutaneous fungal infections in the elderly. Clin Geriatr Med. 2013;29(2):461-478. doi:10.1016/j.cger.2013.01.001.

Loo DS. Cutaneous fungal infections in the elderly. Dermatol Clin. 2004;22(1):33-50. doi:10.1016/s0733-8635(03)00109-8.

Piérard G. Onychomycosis and other superficial fungal infections of the foot in the elderly: a pan-European survey. Dermatology. 2001;202(3):220-224. doi:10.1159/000051640.

Achar A, Ghoshal L, Samanta A, Satpathi PS, Bisai B.A clinico-epidemiological study superficial cutaneous fungal infection in elderly patients.l Venereol Leprol. 2017 Mar-Apr;83(2):205-211.

Martin ES, Elewski BE. Cutaneous fungal infections in the elderly. Clin Geriatr Med. 2002;18(1):59-75. doi:10.1016/s0749-0690(03)00034-x.

Kaul S, Yadav S, Dogra S. Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women. Indian Dermatol Online J. 2017;8(5):310-318. doi:10.4103/idoj.IDOJ_169_17.

Venkatesan S, Tadepalli K, Asati DP, et al. P116 Cutaneous fungal infections in elderly population from Bhopal. Med Mycol. 2022;60(Suppl 1):myac072P116. Published 2022 Sep 20. doi:10.1093/mmy/myac072.P116.

Rotta I, Ziegelmann PK, Otuki MF, Riveros BS, Bernardo NL, Correr CJ. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments. JAMA Dermatol. 2013;149(3):341-349. doi:10.1001/jamadermatol.2013.1721.

van Zuuren EJ, Fedorowicz Z, El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Br J Dermatol. 2015;172(3):616-641. doi:10.1111/bjd.13441.

Williams HC. The epidemiology of onychomycosis in Britain. Br J Dermatol. 1993;129(2):101-109. doi:10.1111/j.1365-2133.1993.tb03510.x.

Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol. 1992;126 Suppl 39:23-27. doi:10.1111/j.1365-2133.1992.tb00005.x.

Vasconcellos C, Pereira CQ, Souza MC, Pelegrini A, Freitas RS, Takahashi JP. Identification of fungi species in the onychomycosis of institutionalized elderly. An Bras Dermatol. 2013;88(3):377-380. doi:10.1590/abd1806-4841.20131884.

Scherer WP, McCreary JP, Hayes WW. The diagnosis of onychomycosis in a geriatric population: a study of 450 cases in South Florida. J Am Podiatr Med Assoc. 2001;91(9):456-464. doi:10.7547/87507315-91-9-456.

Evans EG, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. BMJ. 1999;318(7190):1031-1035. doi:10.1136/bmj.318.7190.1031.

Shivanna R, Rajesh. Management of dermatophytosis in elderly and with systemic comorbidities.Clinical Dermatology Review 1.Suppl 1 (2017): S38-S41.

Yang Z, Chen W, Wan Z, Song Y, Li R. Tinea Capitis by Microsporum canis in an Elderly Female with Extensive Dermatophyte Infection. Mycopathologia. 2021;186(2):299-305. doi:10.1007/s11046-020-00519-9.

Medina D, del Carmen Padilla M, Ferna ́ndez R, Arenas R, Bonifaz A. Tin ̃a de la cabeza en adultos: estudio cl ́ınico, micolo ́gico y epidemiolo ́gico de 30 casos en ciudad de Me ́xico. Piel. 2003;18(8):403–8.

El-Khalawany M, Shaaban D, Hassan H, et al. A multicenter clinicomycological study evaluating the spectrum of adult tinea capitis in Egypt. Acta Dermatovenerol Alp Pannonica Adriat. 2013;22(4):77-82.

Cervetti O., Albini P., Arese V., Ibba F., Novarino M., Panzone M. Tinea capitis in adults. Advances in microbiology 2014. 4, 12-14.

Takwale A, Agarwal S, Holmes SC, Berth-Jones J. Tinea capitis in two elderly women: transmission at the hairdresser. Br J Dermatol. 2001;144(4):898-900. doi:10.1046/j.1365-2133.2001.04154.x.

Hamm H, Schwinn A, Bräutigam M, Weidinger G. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group. Br J Dermatol. 1999;140(3):480-482. doi:10.1046/j.1365-2133.1999.02713.x.

Thomas JE, Lloyd PM. Oral candidiasis in the elderly. Spec Care Dentist. 1985;5(5):222-225. doi:10.1111/j.1754-4505.1985.tb00577.x.

Rothan-Tondeur M, Lancien E, Pialleport T, et al. Prevalence of oropharyngeal candidiasis in geriatric inpatients. J Am Geriatr Soc. 2001;49(12):1741-1742. doi:10.1046/j.1532-5415.2001.49295.x.

Paillaud E, Merlier I, Dupeyron C, Scherman E, Poupon J, Bories PN. Oral candidiasis and nutritional deficiencies in elderly hospitalised patients. Br J Nutr. 2004;92(5):861-867. doi:10.1079/bjn20041264.

Taylor M, Brizuela M, Raja A. Oral Candidiasis. [Updated 2023 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Gabriel S, Hahnel E, Blume-Peytavi U, Kottner J. Prevalence and associated factors of intertrigo in aged nursing home residents: a multi-center cross-sectional prevalence study. BMC Geriatr. 2019;19(1):105. Published 2019 Apr 15. doi:10.1186/s12877-019-1100-8.

Mistiaen P, van Halm-Walters M. Prevention and treatment of intertrigo in large skin folds of adults: a systematic review. BMC Nurs 2010; 9(1):12. https://doi.org/10.1186/1472-6955-9-12.

Lohrmann C: Europäische Pflegequalitätserhebung 8. Institut für Pflegewissenschaft. Medizinische Universität Graz. April 2014;2014.

Valls-Matarín J, del Cotillo-Fuente M, Ribal-Prior R et al. [Incidence of moisture-associated skin damage in an intensive care unit] [in Spanish]. Enferm Intensiva 2017; 28(1):13–20. https://doi.org/10.1016/j. enfi.2016.11.001.

Emre S, Emre C, Akoglu G et al. Evaluation of dermatological consultations of patients treated in intensive care unit. Dermatology 2013; 226(1):75–80. https://doi.org/10.1159/000346939.

Ndiaye M, Taleb M, Diatta BA et al. [Etiology of intertrigo in adults: a prospective study of 103 cases] [in French]. J Mycol Med 2017; 27(1):28–32. https://doi.org/10.1016/j.mycmed.2016.06.001.

Romanelli M, Voegeli D, Colboc H, et al. The diagnosis, management and prevention of intertrigo in adults: a review. J Wound Care. 2023;32(7):411-420. doi:10.12968/jowc.2023.32.7.411.

Fischer G, Bradford J. Vulvovaginal candidiasis in postmenopausal women: the role of hormone replacement therapy. J Low Genit Tract Dis. 2011;15(4):263-267. doi:10.1097/LGT.0b013e3182241f1a.

Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R (. Global burden of recurrent vulvovaginal candidiasis: a systematic review. The Lancet infectious diseases,2018; 18(11), e339-e347.

Vermitsky JP, Self MJ, Chadwick SG, et al. Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection. J Clin Microbiol. 2008;46(4):1501-1503. doi:10.1128/JCM.02485-07.

37.Ignjatović A, Arsić-Arsenijević V, Golubović M, et al. Recurrent Vulvovaginal Candidosis and Cluster Analysis of Clinical Signs and Symptoms: A Laboratory-Based Investigation. J Fungi (Basel). 2020;6(3):113. Published 2020 Jul 22. doi:10.3390/jof6030113.

Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258-1272. doi:10.1177/0956462418785451.

Wray AA, Velasquez J, Khetarpal S. Balanitis. [Updated 2022 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537143/.

Borelli S, Lautenschlager S. Differenzialdiagnose und Management der Balanitis [Differential diagnosis and management of balanitis]. Hautarzt. 2015;66(1):6-11. doi:10.1007/s00105-014-3554-0.

Cohen PR, Scher RK. Geriatric nail disorders: diagnosis and treatment. J Am Acad Dermatol. 1992;26(4):521-531. doi:10.1016/0190-9622(92)70075-q.

Suleman E. S. Nails Changes and Disorders in Elderly Libyans. Mathews Journal of Dermatology,2023.7(1), 1-20.

Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J Am Acad Dermatol. 2002;47(1):73-76. doi:10.1067/mjd.2002.122191.

Relhan V, Goel K, Bansal S, Garg VK. Management of chronic paronychia. Indian J Dermatol. 2014;59(1):15-20. doi:10.4103/0019-5154.123482.

Sowell J, Pena SM, Elewski BE. Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options. Drugs Aging. 2022;39(5):315-321. doi:10.1007/s40266-022-00930-5.

Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51(5):785-798. doi:10.1016/j.jaad.2003.12.034.

Mastrolonardo M, Diaferio A, Vendemiale G, Lopalco P. Seborrhoeic dermatitis in the elderly: inferences on the possible role of disability and loss of self-sufficiency. Acta Derm Venereol. 2004;84(4):285-287. doi:10.1080/00015550410025877.

Kyriakis KP, Terzoudi S, Palamaras I, Pagana G, Michailides C, Emmanuelides S. Pityriasis versicolor prevalence by age and gender. Mycoses. 2006;49(6):517-518. doi:10.1111/j.1439-0507.2006.01285.x.

Gupta AK, Lane D, Paquet M. Systematic review of systemic treatments for tinea versicolor and evidence-based dosing regimen recommendations. J Cutan Med Surg. 2014;18(2):79-90. doi:10.2310/7750.2013.13062.

Saunte DML, Gaitanis G, Hay RJ. Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Front Cell Infect Microbiol. 2020;10:112. Published 2020 Mar 20. doi:10.3389/fcimb.2020.00112.